Pregled bibliografske jedinice broj: 1103960
Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple– negative breast cancer?
Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple– negative breast cancer? // Libri Oncologici Croatian Journal of Oncology, 48 (2020), 1; 20-26 doi:10.20471/lo.2020.48.01.04 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1103960 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Androgen receptors: unclear ubiquitious
mechanism or the missing key in the triple–
negative breast cancer?
Autori
Tečić-Vuger, Ana ; Medical Oncology Department, Division for Radiotherapy and Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia ; Šeparović, Robert ; Vazdar, Ljubica ; Pavlović, Mirjana ; Lepetić, Petra ; Šitić, Sanda ; Šarčević, Božena ; Vrbanec, Damir
Izvornik
Libri Oncologici Croatian Journal of Oncology (0300-8142) 48
(2020), 1;
20-26
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
androgen receptors, breast cancer, triple negative breast cancer
Sažetak
Androgen receptors (AR) are ligand-dependent nuclear transcription factors. These are steroid receptors, similar to estrogen receptors (ER). They are expressed in numerous cells in the body, with different constructive roles. AR signalling can be involved in the development of a variety of human malignant tumors, such as prostate cancer, bladder, liver, salivary glands, kidney, lung, melanoma, sarcoma, breast cancer, and many others. The role of AR is most clear and today best explained in prostate cancer. The mechanism of AR signalling in other human epithelial tumors is still quite unclear and the effects are different to entirely opposite in different tumors. In breast cancer, AR are the most commonly expressed receptors, but still with an incompletely clear role, prognostic and predictive significance. The expression of AR in triple-negative breast cancer (TNBC) is highly variable. Despite the marked differences in the results of the various analyzes, they appear to have a beneficial effect on the prognosis and are potentially the target of antihormone therapy for treatment of TNBC in the future. © 2020 University Hospital for Tumors. All rights reserved.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Interdisciplinarne biotehničke znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
Sveučilište Jurja Dobrile u Puli
Profili:
Sanda Bubanović
(autor)
Ljubica Vazdar
(autor)
Robert Šeparović
(autor)
Mirjana Pavlović
(autor)
Damir Vrbanec
(autor)
Božena Šarčević
(autor)
Ana Tečić Vuger
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus